Johnson & Johnson / Janssen: Clinical Trials & Research Profile

Biopharma Industry (New Brunswick, NJ) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (New Brunswick, NJ)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies122 active (49 recruiting now)
Total Tracked Studies (2018 to 2026)300 (189 with California sites)
Completed vs Early-Stopped Studies123 completed / 55 stopped (18.3% stop rate)
Median Closed Enrollment192 participants
FDA Drugs@FDA Original Approvals131 all-time (21 from 2018 to 2026)
Physical Hospital Site Disclosure99.4% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Johnson & Johnson across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk